Who invested in GenEdit

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$33Mraised across 2 rounds since 2018, from 2 sources

$8.5MRound$24MSeries A

Latest round: Series A, $24MJan 2024
Step-upi: 2.8×
Investors: 8

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021202220232024

$8.5MRound$24MSeries A

First round: Round, $8.5M
Biggest round: $24M
Between rounds: 5.1 years

The rounds

Jan 2024
Series A$24M5 new
Source recorded
Dec 2018
Round$8.5M3 new
- Bow Capital
- Data Collective Bio
- SK Holdings/ Sequoia
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2018Series A2024

Sequoia Capital

National Science Foundation

Qiming Venture Partners

DCVC

Eli Lilly

Bow CapitalData Collective BioSK Holdings/ Sequoia

Everyone who backed them

Sequoia CapitalVC firm1round

National Science FoundationGovernment1round

Qiming Venture PartnersVC firm1round

DCVCVC firm1round

Eli LillyCorporate VC1round

Bow CapitalVC firm1round

Data Collective Biono record of our own yet1round

SK Holdings/ Sequoiano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists GenEdit as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.